XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 54 filers reported holding XERIS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $121,000 | -7.6% | 26,788 | +0.3% | 0.00% | – |
| Q4 2020 | $131,000 | -19.6% | 26,717 | -2.8% | 0.00% | -100.0% |
| Q3 2020 | $163,000 | +167.2% | 27,484 | +20.4% | 0.00% | – |
| Q2 2020 | $61,000 | +48.8% | 22,831 | +8.3% | 0.00% | – |
| Q1 2020 | $41,000 | -65.3% | 21,090 | +26.3% | 0.00% | – |
| Q4 2019 | $118,000 | -28.9% | 16,696 | -0.8% | 0.00% | -100.0% |
| Q3 2019 | $166,000 | -14.4% | 16,838 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $194,000 | +48.1% | 16,954 | +29.8% | 0.00% | – |
| Q1 2019 | $131,000 | +74.7% | 13,058 | +196.6% | 0.00% | – |
| Q4 2018 | $75,000 | -2.6% | 4,403 | +0.3% | 0.00% | – |
| Q3 2018 | $77,000 | – | 4,390 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 4,172,459 | $20,528,000 | 1.31% |
| DELTEC ASSET MANAGEMENT LLC | 693,870 | $3,414,000 | 0.52% |
| Alpine Global Management, LLC | 350,000 | $1,722,000 | 0.35% |
| Redmile Group, LLC | 2,397,441 | $11,795,000 | 0.14% |
| Kamunting Street Capital Management, L.P. | 43,833 | $216,000 | 0.11% |
| IHT Wealth Management, LLC | 250,798 | $1,234,000 | 0.10% |
| SEARLE & CO. | 34,000 | $167,000 | 0.08% |
| GPS Wealth Strategies Group, LLC | 46,025 | $226,000 | 0.08% |
| ArrowMark Colorado Holdings LLC | 1,981,909 | $9,751,000 | 0.08% |
| Gladstone Institutional Advisory LLC | 51,500 | $253 | 0.05% |